foxo4-dri senolytic peptide human trial 2024 2025 The disordered p53 transactivation domain is the target of FOXO4 and the compound Quantity:3 PCS nad+ bpc 157 peptide Skin Support
SKU: 11039757496
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5





















